Under hypoxic conditions, vascular distant HNSCC cells displayed a lower expression of the Epidermal Growth Factor Receptor (EGFRs), which may underlie anti-EGFR therapy resistance [229]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.